In the News August 25, 2020

Pink Sheet | What the FDA’s Inspections Q&A Guidance Really Means: It’s Time to Offer Virtual Inspections

Cathy Burgess is quoted on recent guidance by the U.S. Food and Drug Administration that could include virtual inspections of manufacturing sites amid COVID-19 and how the industry should continue urging the FDA to adopt these new approaches.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.